127 related articles for article (PubMed ID: 15273951)
1. Covariate adjustment in clinical trials with non-ignorable missing data and non-compliance.
Levy DE; O'Malley AJ; Normand SL
Stat Med; 2004 Aug; 23(15):2319-39. PubMed ID: 15273951
[TBL] [Abstract][Full Text] [Related]
2. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
O'Malley AJ; Normand SL
Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
[TBL] [Abstract][Full Text] [Related]
3. Non-parametric bounds on treatment effects with non-compliance by covariate adjustment.
Cai Z; Kuroki M; Sato T
Stat Med; 2007 Jul; 26(16):3188-204. PubMed ID: 17136775
[TBL] [Abstract][Full Text] [Related]
4. Discrete state analysis for interpretation of data from clinical trials.
Sugar CA; James GM; Lenert LA; Rosenheck RA
Med Care; 2004 Feb; 42(2):183-96. PubMed ID: 14734956
[TBL] [Abstract][Full Text] [Related]
5. Marginalized transition models for longitudinal binary data with ignorable and non-ignorable drop-out.
Kurland BF; Heagerty PJ
Stat Med; 2004 Sep; 23(17):2673-95. PubMed ID: 15316952
[TBL] [Abstract][Full Text] [Related]
6. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements.
Lui KJ
Stat Med; 2007 Jul; 26(16):3140-56. PubMed ID: 17177272
[TBL] [Abstract][Full Text] [Related]
7. An autoregressive linear mixed effects model for the analysis of longitudinal data which include dropouts and show profiles approaching asymptotes.
Funatogawa T; Funatogawa I; Takeuchi M
Stat Med; 2008 Dec; 27(30):6351-66. PubMed ID: 18767204
[TBL] [Abstract][Full Text] [Related]
8. Estimation of the risk difference under a noncompliance randomized clinical trial with missing outcomes.
Lui KJ
J Biopharm Stat; 2008; 18(2):273-92. PubMed ID: 18327721
[TBL] [Abstract][Full Text] [Related]
9. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
Taylor L; Zhou XH
Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
Advokat C
Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
[TBL] [Abstract][Full Text] [Related]
11. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
Taylor DM; Smith L
Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
[TBL] [Abstract][Full Text] [Related]
13. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
[TBL] [Abstract][Full Text] [Related]
14. Pseudo-likelihood methods for longitudinal binary data with non-ignorable missing responses and covariates.
Parzen M; Lipsitz SR; Fitzmaurice GM; Ibrahim JG; Troxel A
Stat Med; 2006 Aug; 25(16):2784-96. PubMed ID: 16345018
[TBL] [Abstract][Full Text] [Related]
15. On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?
Bang H; Davis CE
Stat Med; 2007 Feb; 26(5):954-64. PubMed ID: 16900559
[TBL] [Abstract][Full Text] [Related]
16. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
17. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
Jo B
Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
[TBL] [Abstract][Full Text] [Related]
18. Dealing with missing outcome data in randomized trials and observational studies.
Groenwold RH; Donders AR; Roes KC; Harrell FE; Moons KG
Am J Epidemiol; 2012 Feb; 175(3):210-7. PubMed ID: 22262640
[TBL] [Abstract][Full Text] [Related]
19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
20. Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia.
Citrome L
Int J Clin Pract; 2008 May; 62(5):837-40. PubMed ID: 18412940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
